Evidence map›Paper›PMID 40184427›Full record

ArticlePLoS genetics2025

ClpP2 proteasomes and SpxA1 determine Listeria monocytogenes tartrolon B hyper-resistance.

Tim Engelgeh, Sabrina Wamp, Patricia Rothe, Jennifer Herrmann, Martin A Fischer, Rolf Müller, Sven Halbedel

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Effect of Ammonia onAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tim EngelgehFG11 Division of Enteropathogenic bacteria and Legionella, Robert Koch Institute, Wernigerode, Germany.ORCID https://orcid.org/0000-0003-1609-2299
Sabrina WampFG11 Division of Enteropathogenic bacteria and Legionella, Robert Koch Institute, Wernigerode, Germany.ORCID https://orcid.org/0000-0002-0387-4171
Patricia RotheFG11 Division of Enteropathogenic bacteria and Legionella, Robert Koch Institute, Wernigerode, Germany.
Jennifer HerrmannDepartment of Microbial Natural Products, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Martin A FischerFG13 Division of Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany.
Rolf MüllerDepartment of Microbial Natural Products, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Sven HalbedelFG11 Division of Enteropathogenic bacteria and Legionella, Robert Koch Institute, Wernigerode, Germany.ORCID https://orcid.org/0000-0002-5575-8973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The foodborne bacterium Listeria monocytogenes is transmitted to humans from various environmental sources through consumption of contaminated plant and animal-based food. L. monocytogenes uses ATP-binding cassette (ABC)-type drug transporters to resist antimicrobial compounds produced by competitors co-residing in its environmental reservoirs. We have shown previously that the TimAB transporter confers resistance of L. monocytogenes to tartrolon B, a boron containing macrodiolide produced by myxo- and proteobacterial species. Tartrolon B acts as a potassium ionophore and is sensed by TimR, the transcriptional repressor of timABR operon. We here have isolated tartrolon B resistant suppressor mutations outside the timABR locus. These mutations inactivated the clpP2 gene, which encodes the main proteolytic component of house-keeping Clp proteases. Deletion of clpP2 impaired growth and virulence but caused tartrolon B hyper-resistance. This phenotype was timAB-dependent, but neither production nor degradation of TimAB was affected upon clpP2 inactivation. Combinatorial deletions of the genes encoding the three Clp ATPases showed that ClpCP2 and ClpXP2 proteasomes jointly promote tartrolon B hyper-resistance. Genetic follow-up experiments identified the ClpP2 substrate and transcription factor SpxA1 and its protease adaptor YjbH as further tartrolon B resistance determinants. SpxA1 activates transcription of the cydABCD operon encoding cytochrome oxidase and in accordance with this transposon mutants with impaired cytochrome oxidase function were depleted from a transposon mutant library during tartrolon B exposure. Our work demonstrates novel roles of Clp proteasomes, SpxA1 and cytochrome oxidase CydAB in the resistance against compounds dissipating transmembrane ion gradients and helps to better understand the genetic and chemical basis of the manifold ecological interactions of an important human pathogen in its natural ecologic niches.

Indexed as

Bacterial ProteinsDrug Resistance, BacterialEndopeptidase ClpListeria monocytogenesProteasome Endopeptidase ComplexATP-Binding Cassette TransportersGene Expression Regulation, BacterialHumansMutationOperonVirulenceATP-Binding Cassette TransportersBacterial ProteinsEndopeptidase ClpProteasome Endopeptidase Complex

Identifiers

PMID40184427
PMCPMC11970672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.